F
Francesca Zimetti
Researcher at University of Parma
Publications - 81
Citations - 2079
Francesca Zimetti is an academic researcher from University of Parma. The author has contributed to research in topics: Cholesterol & Internal medicine. The author has an hindex of 21, co-authored 55 publications receiving 1462 citations.
Papers
More filters
Journal ArticleDOI
Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation
Ryan E. Moore,Mohamad Navab,John S. Millar,Francesca Zimetti,Susan Hama,George H. Rothblat,Daniel J. Rader +6 more
TL;DR: It is concluded that apoA-I inhibits atherosclerosis by promoting both macrophage reverse cholesterol transport and HDL antiinflammatory function, and that these anti-atherogenic functions of apo-I are largely independent of the plasma level of HDL-C in this mouse model.
Journal ArticleDOI
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis
TL;DR: Although some polyphenols might improve specific markers of cardiovascular risk and cognitive status, many inconsistent data are present in literature, therefore, definitive recommendations for the use of these compounds in the prevention of cardiovascular disease and cognitive decline are currently not applicable.
Journal ArticleDOI
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
Nicoletta Ronda,Elda Favari,Maria Orietta Borghi,Francesca Ingegnoli,Maria Gerosa,Cecilia Beatrice Chighizola,Francesca Zimetti,Maria Pia Adorni,Franco Bernini,Pier Luigi Meroni +9 more
TL;DR: In this paper, the capacity of high-density lipoproteins (HDL) to promote cell cholesterol efflux is investigated in rheumatoid arthritis (RA) and systemic lupus erythemathosus (SLE) patients.
Journal ArticleDOI
Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux
Elda Favari,Ilaria Zanotti,Francesca Zimetti,Nicoletta Ronda,Franco Bernini,George H. Rothblat +5 more
TL;DR: Probucol is an effective inhibitor of ABCA1-mediated cholesterol efflux without influencing scavenger receptor class B type I–mediated efflux, which may in part explain the reported in vivo high-density lipoprotein–lowering action of probucol.
Journal ArticleDOI
Depletion of Pre-β-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein
Elda Favari,Miriam Lee,Laura Calabresi,Guido Franceschini,Francesca Zimetti,Franco Bernini,Petri T. Kovanen +6 more
TL;DR: The results indicate that chymase treatment of HDL3 specifically impairs the ABCA1-dependent pathway without influencing either aqueous or SR-BI-facilitated diffusion and that this effect is caused by depletion of lipid-poor pre-β-migrating particles in HDL3.